Related Experiment Video
Updated: Sep 11, 2025

08:37
Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
Published on: April 18, 2025
538
mTOR Signaling in Macrophages: All Depends on the Context
Angelika Fedor1, Krzysztof Bryniarski1, Katarzyna Nazimek1
1Department of Immunology, Jagiellonian University Medical College, Czysta 18, 31-121 Kraków, Poland.
International Journal of Molecular Sciences
|August 14, 2025
Summary
Mammalian target of rapamycin (mTOR) signaling in macrophages is crucial for immune responses and metabolism. Its modulation for autoimmune diseases requires careful consideration of context-dependent effects and microRNA regulation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Macrophages are key immune cells involved in numerous biological processes.
- Dysregulated macrophage activity is linked to various disorders, notably autoimmune diseases.
- Mammalian target of rapamycin (mTOR) signaling pathways are activated by inflammatory signals and regulate cell survival and metabolism.
Purpose of the Study:
- To review recent advances in understanding mTOR signaling activation in macrophages.
- To focus on the role of mTOR in autoimmune disorders.
- To explore the potential for microRNA-mediated control of mTOR in macrophages.
Main Methods:
- Narrative review of existing research.
- Synthesis of studies on mTOR signaling, macrophages, and autoimmune diseases.
- Analysis of microRNA regulation of mTOR pathways.
Main Results:
- mTOR signaling is activated by cytokines and inflammatory mediators.
- MicroRNAs can epigenetically regulate mTOR pathways.
- The effects of mTOR modulation in macrophages are highly context-dependent.
Conclusions:
- Modulating mTOR pathways in macrophages for therapeutic purposes requires careful consideration of the specific immunological context.
- Understanding the interplay between mTOR, macrophages, and microRNAs is critical for developing treatments for autoimmune diseases.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K

